TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 2 | 1 | 2 | 0 | -6 | -11 | -31 | -28 | -53 | -26 |
| S | %wins | 50 | 50 | 100 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/8/15 13:07 | 5/1/15 | LBIO | Lion Biotechnologies, Inc. | NV | Health | BioPrd | Biological Products, (No Diag | Ayer Capital Management, LP | NY | T | S | -26,752 | 9.62 | 6 | -2,781 | -50 | 2,823 | I | 999 | 33 | 70 | 52 | 0 | -5 | -4 | -5 | -3 | -13 | -8 | -31 | -41 | -55 | |
6/29/12 17:13 | 6/28/12 | ACCP | Access Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Ayer Capital Management, LP | CA | T | S.m | -116 | 0.5679 | 0 | -204 | -8 | 2,413 | I | |||||||||||||||
5/16/12 17:47 | 5/16/12 | ACCP | Access Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Ayer Capital Management, LP | CA | T | S.m | -95 | 0.6713 | 0 | -141 | -5 | 2,758 | I | |||||||||||||||
6/27/11 17:14 | 6/23/11 | ONTY | Oncothyreon Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Ayer Capital Management, LP | CA | T | S | -253 | 8.74 | 16 | -29 | -1 | 2,985 | I | 190 | 164 | 156 | 126 | 51 | 44 | 21 | 5 | 3 | 1 | -14 | -30 | -15 | -50 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |